JillPCrandallMD
Endocrinology • Bronx, NYDiabetes, Obesity
Professor, Medicine, Endocrinology, Albert Einstein College of Medicine Chief, Division of Endocrinology
Dr. Crandall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1180 Morris Park Ave
Bronx, NY 10461Phone+1 866-633-8255
Summary
- Dr. Jill Crandall is an endocrinologist in Bronx, NY and is chief of the Division of Endocrinology at Montefiore Medical Center / Albert Einstein College of Medicine. She received her medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 29 years. She specializes in diabetes and obesity and is an experienced clinical investigator. She has more than 100 publications and over 500 citings.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 1991 - 1994- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1988 - 1991
State University of New York Downstate Medical Center College of MedicineClass of 1988
Certifications & Licensure
NY State Medical License 1989 - 2025
Clinical Trials
- Diabetes Prevention Program Outcomes Study Start of enrollment: 2002 Sep 01
- Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance Start of enrollment: 2011 Apr 01
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- 310 citationsStatin Therapy and Risk of Developing Type 2 Diabetes: A Meta-AnalysisSwapnil Rajpathak, Dharam J. Kumbhani, Jill P. Crandall, Nir Barzilai, Michael H. Alderman
Diabetes Care. 2009-10-01 - 22 citationsGlycemic Control and Cardiovascular Disease: What’s a Doctor to Do?Preeti Kishore, Sharon H. Kim, Jill P. Crandall
Current Diabetes Reports. 2012-04-01 - 126 citationsAdiponectin, change in adiponectin, and progression to diabetes in the diabetes prevention programKieren J. Mather, Tohru Funahashi, Yuji Matsuzawa, Sharon L. Edelstein, George A. Bray
Diabetes. 2008-04-01
Press Mentions
Continuous Glucose Monitors for All? Opinions Remain MixedNovember 12th, 2024- Low-Carb Diet May Enable Type 2 Diabetics to Reduce MedicationOctober 22nd, 2024
- New Research Suggests GLP-1 Drugs like Ozempic May Reduce Cancer RiskSeptember 6th, 2024
- Join now to see all
Grant Support
- Diabetes Prevention Program Long-Term Follow-Up StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
- Humanin And Type 2 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Clinical CoreNational Institute On Aging2007–2011
- Post-Dpp Follow-Up StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
- DpposNational Center For Research Resources2004–2008
- CvriskNational Center For Research Resources2004–2008
- Post-Dpp Follow-Up StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2003
- Thrombogenicity In Diabetes MellitusNational Center For Research Resources1999–2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
